feed,title,long_url,short_url
Benzinga,Outlook Therapeutics' Bevacizumab-vikg Shows Favorable Safety Profile In Retinal Disease Study,https://benzinga.com/general/biotech/21/03/20421879/outlook-therapeutics-bevacizumab-vikg-shows-favorable-safety-profile-in-retinal-disease-study,https://j.mp/3wcCfJn
